Available data indicate a worse prognosis in cancer patients with COVID-19. Surgical treatment of lung cancer in the conditions of the COVID-19 pandemic poses new challenges to ensure the perioperative safety of patients.

OBJECTIVE

To prevent infection of patients in the perioperative period and, in case of infection, to prevent the severe course of COVID-19.

MATERIAL AND METHODS

In the conditions of the COVID-19 pandemic within two months (March—April 2020) 138 patients underwent surgical treatment for malignant tumors, including 22 videothoracoscopic operations: 3 (13.6%) segmentectomies, 16 (72.7%) lobectomies, and 5 (22.7%) bilobectomies for non-small cell lung cancer.

RESULTS AND CONCLUSIONS

Following the principles that ensure the prevention of infection and the prevention of severe COVID-19, we managed to avoid the first stage of the pandemic (March—April 2020) cases of infection with a new coronavirus infection in patients who underwent surgical treatment for lung cancer.